Skip to main content
PolicySpeak
← All files
HAL

Haleon

Company · Belgium · EU Transparency Register 292566647414-46

2
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
2
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1212 companies & groups on this site, they rank #667 by legislative files engaged, a count of participation, not a measure of influence.

1.3
declared lobbying FTE
self-declared
€600K+
declared costs / yr (floor)
3
EP accreditations
as declared to the register
2022
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 15 Oct 2026).

Register category
Companies & groups
Head office
Weybridge, United kingdom
EU office
Brussels

Self-declared to the EU Transparency Register (snapshot 15 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Haleon in PolicySpeak: request access →

Follow Haleon

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at Haleon? so we know who speaks for it.

Their record over time

Haleon filed 2 positions between 13 Mar 2023 and 6 Nov 2023, across 2 of the 665 legislative files tracked here, attaching a full position paper 2 times.

What they argued

Packaging and packaging wastefiled 13 Mar 2023PDFsource

We welcome the European Commissions proposal for a Regulation on Packaging and Packaging Waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC. We particularly support the free movement within the EU of all types of packaging materials and harmonised criteria for sorting packaging waste.

Medicinal products for human usefiled 6 Nov 2023PDFsource

Haleon, a global leader in consumer health with a purpose to deliver better everyday health with humanity, welcomes the overall objectives of the European Commissions proposal for a revision of the EUs General Pharmaceutical Legislation. We also acknowledge and commend the patient-centred approach that the European Commission has chosen to adopt in its Pharmaceutical Strategy.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Haleon next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 17.

Is this your organization?

Everything on this page comes from Haleon’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.